03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Buvidal 8mg : | |
Type | Medicine Authorised |
Originator | B |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Camurus |
Responsible Party | Camurus AB |
Origin | Sweden |
Manufacturer | Rechon Life Science AB |
Origin | Sweden |
ATC | N07BC01 |
Buvidal 8mg :
Buvidal 8mg :
Buvidal 8mg :
Buvidal 8mg :
Buvidal 8mg :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Buvidal 8mg :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Agitation | Common |
ALT increased | Uncommon |
Anxiety | Common |
Arthralgia (Pain joint) (Joint ache) | Common |
AST increased | Uncommon |
Asthenia | Common |
Asthma | Common |
Back pain | Common |
Bone pain | Common |
Bronchitis | Common |
Chest pain | Common |
Chills | Common |
Constipation | Common |
Cough | Common |
Decreased appetite | Common |
Dependence | Common |
Depression | Common |
Diarrhoea (Diarrhea) | Common |
Dizziness | Common |
Drug withdrawal syndrome | Very Common |
Dry mouth (Xerostomia) | Common |
Dysmenorrhoea | Common |
Dyspepsia | Common |
Dyspnoea (dyspnea) | Common |
Erythema | Not known |
Euphoric mood | Not known |
Flatulence | Common |
Gastrointestinal disorders | Common |
Hallucination | Not known |
Headache | Very Common |
Hepatic enzyme increased | Uncommon |
Hostility | Common |
Hyperhidrosis | Very Common |
Hypersensitivity | Common |
Hypertonia | Common |
Hypotension | Common |
Infection | Common |
Influenza | Common |
Injection site bruising | Uncommon |
Injection site cellulitis | Uncommon |
Injection site erythema | Common |
Injection site induration | Common |
Injection site inflammation | Uncommon |
Injection site mass | Common |
Injection site pain | Common |
Injection site pruritus | Common |
Injection site reaction | Common |
Injection site swelling | Common |
Injection site urticaria | Uncommon |
Insomnia | Very Common |
Lacrimal disorder | Common |
Liver function test abnormal | Common |
Lymphadenopathy | Common |
Malaise | Common |
Migraine | Common |
Miosis | Common |
Muscle spasms | Common |
Myalgia | Common |
Mydriasis (dilated pupils) (Dilatation pupillary) | Common |
Nausea | Very Common |
Neck pain | Common |
Nervousness | Common |
Oedema peripheral | Common |
Pain | Very Common |
Palpitations | Common |
Paraesthesia (paresthesia) | Common |
Paranoia | Common |
Pharyngitis | Common |
Procedural dizziness | Uncommon |
Pruritus | Common |
Pyrexia | Common |
Rash both legs | Common |
Rash macular | Uncommon |
Rhinitis | Common |
Somnolence | Common |
Speech disorder | Common |
Syncope | Common |
Thinking abnormal (Thinking disturbances) | Common |
Tremor | Common |
Urinary retention | Not known |
Urticaria | Common |
Vasodilation | Common |
Vertigo | Uncommon |
Vomiting | Common |
Withdrawal syndrome neonatal | Common |
Yawning | Common |
Buvidal 8mg :
NB : Products With Same Indication |
Different Units By MoH Code
Buvidal 8mg MoH 10716 :
Form | Prolonged-release solution for injection |
Packaging | Pre-filled Syringe |
Package Size | 1x0.16ml |
Strength | 8mg |
Public Price | 8524771 L.L. |
Stratum | C |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 58921/1 |
Submission date | 28\04\2021 |
Registration Year | 28/09/2021 |
Price Comparison
● Country: | Lebanon | |
● Form: | Prolonged-release solution for injection | |
● Package Size: | 1x0.16ml | |
● Public Price: | 8524771 LBP | ( 8,524,771.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 8524771 LBP | ( 8,524,771.00 LBP ) |
● Pricing Date: | 13/06/2024 |
Note
● Cost/Unit: | 8524771 LBP | ( 8,524,771.00 LBP ) |
● Cost/Day: | 8524771 LBP | ( 8,524,771.00 LBP ) |
● Cost/Month: | 34099084 LBP | ( 34,099,084.00 LBP ) |
You have to register to view this info
Drop File